Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|August 12, 2020
Active learning for efficiently training emulators of computationally expensive mathematical modelsAlexandra G Ellis, Rowan Iskandar, Christopher H Schmid, et al.
Cost Effectiveness and Resource Allocation : C/E|October 12, 2020
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in USPraveen Thokala, Matt Stevenson, Varun M Kumar, et al.
American Journal of Epidemiology|October 10, 2017
Propensity Score-Based Methods in Comparative Effectiveness Research on Coronary Artery DiseaseAlexandra G Ellis, Thomas A Trikalinos, Benjamin S Wessler, et al.
Journal of Comparative Effectiveness Research|August 2, 2023
Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia veraAaron T Gerds, Claudia Castro, Frank Snopek, et al.
Molecular Genetics and Metabolism|July 26, 2021
Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United StatesBarbara K Burton, Alexandra G Ellis, Blair Orr, et al.
Journal of Medical Economics|December 10, 2025
Budget impact of suzetrigine for the treatment of moderate-to-severe acute pain in Medicaid-insured adultsKenna Garrison, Alexandra G Ellis, Tammy G Curtice, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysisAlexandra G Ellis, Jean-Yves Reginster, Xuemei Luo, et al.
Journal of the American Heart Association|October 26, 2017
Advanced Age and Post-Acute Care Outcomes After Subarachnoid HemorrhageCorey R Fehnel, William B Gormley, Hormuzdiyar Dasenbrock, et al.
Current Medical Research and Opinion|April 30, 2014
Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic womenAlexandra G Ellis, Jean-Yves Reginster, Xuemei Luo, et al.
JAMA Dermatology|March 16, 2022
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysisAaron M Drucker, Deanna E Morra, David Prieto-Merino, et al.
Pageof 2